Total Payments
$1,285
2024 Payments
$164.10
Companies
23
Transactions
83
Medicare Patients
892
Medicare Billing
$114,989
Payment Breakdown by Category
Food & Beverage$1,285 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,285 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $240.40 | 15 | $0 (2024) |
| PFIZER INC. | $189.63 | 13 | $0 (2024) |
| AbbVie Inc. | $157.45 | 12 | $0 (2023) |
| Eisai Inc. | $93.02 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $75.85 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $66.87 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $62.63 | 4 | $0 (2022) |
| Lilly USA, LLC | $57.45 | 4 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $47.17 | 4 | $0 (2018) |
| Allergan, Inc. | $38.94 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $164.10 | 7 | Eisai Inc. ($93.02) |
| 2023 | $140.65 | 8 | PFIZER INC. ($33.14) |
| 2022 | $326.54 | 22 | ABBVIE INC. ($143.73) |
| 2021 | $31.55 | 2 | GlaxoSmithKline, LLC. ($16.66) |
| 2020 | $42.37 | 3 | Allergan, Inc. ($26.78) |
| 2019 | $143.13 | 9 | Novo Nordisk Inc ($36.34) |
| 2018 | $130.25 | 10 | Novo Nordisk Inc ($28.09) |
| 2017 | $305.95 | 22 | Novo Nordisk Inc ($86.88) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $39.75 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Neurology | ||||||
| 05/14/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: WOMENS HEALTH | ||||||
| 04/10/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Respiratory | ||||||
| 08/16/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Insulin Pump | ||||||
| 05/10/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/23/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/15/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: ETONOGESTREL | ||||||
| 02/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.66 | General |
| 07/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 30 | 38 | $8,612 | $2,278 |
| 2022 | 9 | 250 | 475 | $69,243 | $31,897 |
| 2021 | 9 | 240 | 462 | $64,929 | $30,487 |
| 2020 | 14 | 372 | 711 | $105,870 | $50,327 |
Total Patients
892
Total Services
1,686
Medicare Billing
$114,989
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 61 | 309 | $35,201 | $20,391 | 57.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 32 | $14,604 | $5,049 | 34.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 29 | 55 | $6,266 | $3,748 | 59.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 57 | $9,138 | $3,229 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $3,947 | $3,091 | 78.3% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 23 | 26 | $4,230 | $2,559 | 60.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 31 | $7,206 | $2,543 | 35.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 26 | 34 | $2,943 | $1,743 | 59.2% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2020 | 17 | 18 | $2,541 | $1,583 | 62.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 14 | 16 | $3,749 | $1,329 | 35.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 21 | 22 | $4,490 | $1,193 | 26.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 15 | 15 | $1,608 | $1,013 | 63.0% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 22 | 26 | $5,216 | $964.89 | 18.5% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2020 | 14 | 14 | $1,292 | $809.07 | 62.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 12 | 12 | $1,039 | $655.70 | 63.1% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 11 | 16 | $2,399 | $426.05 | 17.8% |
About Dr. Thomas Stevens, DO
Dr. Thomas Stevens, DO is a General Practice healthcare provider based in Grafton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2013. The National Provider Identifier (NPI) number assigned to this provider is 1659719698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Stevens, DO has received a total of $1,285 in payments from pharmaceutical and medical device companies, with $164.10 received in 2024. These payments were reported across 83 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,285).
As a Medicare-enrolled provider, Stevens has provided services to 892 Medicare beneficiaries, totaling 1,686 services with total Medicare billing of $114,989. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Grafton, WV
- Active Since 06/12/2013
- Last Updated 08/29/2016
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1659719698
Products in Payments
- Leqembi (Drug) $93.02
- DALVANCE (Drug) $92.38
- ENTRESTO (Drug) $75.85
- ELIQUIS (Drug) $75.48
- Ozempic (Drug) $65.90
- QULIPTA (Drug) $52.03
- VRAYLAR (Drug) $51.98
- FARXIGA (Drug) $51.65
- Victoza (Drug) $45.49
- PREVNAR - 13 (Biological) $44.19
- Levemir (Drug) $36.54
- TRADJENTA (Drug) $35.42
- Tresiba (Drug) $35.34
- ASMANEX (Drug) $34.74
- MOUNJARO (Drug) $34.55
- Omnipod (Device) $24.13
- KEVEYIS (Drug) $23.56
- LYRICA (Drug) $23.41
- NUEDEXTA (Drug) $23.14
- STIOLTO RESPIMAT (Drug) $22.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Grafton
Dr. Kurt Kwiatkowski, D.d.s, D.D.S
General Practice — Payments: $50,554
General Practice $50,554
Dr. Rasha Hamouri, Dmd, DMD
General Practice — Payments: $2,738
General Practice $2,738
Dr. Christa Garcia, Dds, DDS
General Practice — Payments: $2,146
General Practice $2,146
Dr. Scott Winter, Dds, DDS
General Practice — Payments: $739.58
General Practice $739.58
Dr. Scott Golrich, Dmd, DMD
General Practice — Payments: $438.19
General Practice $438.19
Dr. John Byers, Dds, Pllc, DDS, PLLC
General Practice — Payments: $275.59
General Practice $275.59